Literature DB >> 15094997

[Diagnosis and treatment of chronic anastomotic fistulas].

M Sailer1, D Bussen, A Thiede.   

Abstract

Treatment of anastomotic fistulas generally implies an individualized concept. The origin of these complications is multifactorial and comprises such factors as primary operation, oncologic situation, comorbidity, and patient age as well as fistula-specific considerations such as anatomic localization, secretion volume, etc. In the case of high-output fistulas, it is of great importance to counteract fluid and electrolyte imbalances. Furthermore, skin maceration due to aggressive secretion needs to be averted. Therapeutic options include operative and endoscopic interventions. Octreotide plays a role in high-output and pancreatic fistulas. Any underlying ailment (e.g., Crohn's disease) requires an optimal disease-specific treatment which characterizes an interdisciplinary approach to such fistulas. The following article discusses general and site-specific considerations in the diagnosis and treatment of anastomotic fistulas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094997     DOI: 10.1007/s00104-004-0877-x

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  15 in total

1.  Does technique of anastomosis play any role in developing late perianal abscess or fistula?

Authors:  I E Gecim; B G Wolff; J H Pemberton; R M Devine; R R Dozois
Journal:  Dis Colon Rectum       Date:  2000-09       Impact factor: 4.585

Review 2.  Complications of pancreatic cancer resection.

Authors:  C M Halloran; P Ghaneh; L Bosonnet; M N Hartley; R Sutton; J P Neoptolemos
Journal:  Dig Surg       Date:  2002       Impact factor: 2.588

Review 3.  [Surgical standard therapy for cancer of the pancreas].

Authors:  H Friess; J Kleeff; L Fischer; M Müller; M W Büchler
Journal:  Chirurg       Date:  2003-03       Impact factor: 0.955

4.  [Postoperative fistulas. How to close them].

Authors:  U Baumgartner
Journal:  MMW Fortschr Med       Date:  2002-11-07

5.  Postoperative morbidity and mortality of pancreaticoduodenectomy for periampullary cancer.

Authors:  F F Chou; S M Sheen-Chen; Y S Chen; M C Chen; C L Chen
Journal:  Eur J Surg       Date:  1996-06

Review 6.  An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma.

Authors:  Alexander Stojadinovic; Ari Brooks; Axel Hoos; David P Jaques; Kevin C Conlon; Murray F Brennan
Journal:  J Am Coll Surg       Date:  2003-06       Impact factor: 6.113

7.  Occlusion of the pancreatic duct versus pancreaticojejunostomy: a prospective randomized trial.

Authors:  Khe Tran; Casper Van Eijck; Valerio Di Carlo; Wim C J Hop; Alessandro Zerbi; Gianpaolo Balzano; Hans Jeekel
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

8.  A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy.

Authors:  C J Yeo; J L Cameron; M M Maher; P K Sauter; M L Zahurak; M A Talamini; K D Lillemoe; H A Pitt
Journal:  Ann Surg       Date:  1995-10       Impact factor: 12.969

9.  [Risk of surgical therapy of stomach cancer in Germany. Results of the German 1992 Stomach Cancer Study. German Stomach Cancer Study Group ('92)].

Authors:  K Böttcher; J R Siewert; J D Roder; R Busch; P Hermanek; H J Meyer
Journal:  Chirurg       Date:  1994-04       Impact factor: 0.955

10.  Indeterminate colitis predisposes to perineal complications after ileal pouch-anal anastomosis.

Authors:  W A Koltun; D J Schoetz; P L Roberts; J J Murray; J A Coller; M C Veidenheimer
Journal:  Dis Colon Rectum       Date:  1991-10       Impact factor: 4.585

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.